[go: up one dir, main page]

ZA200903115B - Freeze-dried injectable pharmaceutical combination of semisynthetic vinca alkaloids and carbohydrate stable at room temperature - Google Patents

Freeze-dried injectable pharmaceutical combination of semisynthetic vinca alkaloids and carbohydrate stable at room temperature

Info

Publication number
ZA200903115B
ZA200903115B ZA200903115A ZA200903115A ZA200903115B ZA 200903115 B ZA200903115 B ZA 200903115B ZA 200903115 A ZA200903115 A ZA 200903115A ZA 200903115 A ZA200903115 A ZA 200903115A ZA 200903115 B ZA200903115 B ZA 200903115B
Authority
ZA
South Africa
Prior art keywords
freeze
room temperature
pharmaceutical combination
vinca alkaloids
injectable pharmaceutical
Prior art date
Application number
ZA200903115A
Other languages
English (en)
Inventor
Elie Leverd
Joel Bougaret
Marie-Dominique Ibarra
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38293420&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200903115(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of ZA200903115B publication Critical patent/ZA200903115B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
ZA200903115A 2006-12-29 2009-05-06 Freeze-dried injectable pharmaceutical combination of semisynthetic vinca alkaloids and carbohydrate stable at room temperature ZA200903115B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0656044A FR2910812B1 (fr) 2006-12-29 2006-12-29 Compositions pharmaceutiques injectables lyophilisees de derives hemi-synthetiques d'alcaloide de vinca stables a temperature ambiante

Publications (1)

Publication Number Publication Date
ZA200903115B true ZA200903115B (en) 2010-04-28

Family

ID=38293420

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200903115A ZA200903115B (en) 2006-12-29 2009-05-06 Freeze-dried injectable pharmaceutical combination of semisynthetic vinca alkaloids and carbohydrate stable at room temperature

Country Status (23)

Country Link
US (1) US8304424B2 (xx)
EP (1) EP2120934B1 (xx)
JP (1) JP2010514737A (xx)
KR (1) KR20090097883A (xx)
CN (1) CN101534821B (xx)
AR (1) AR064715A1 (xx)
AU (1) AU2007341231B2 (xx)
BR (1) BRPI0722076A2 (xx)
CA (1) CA2673232A1 (xx)
CL (1) CL2007003838A1 (xx)
FR (1) FR2910812B1 (xx)
IL (1) IL199556A (xx)
MA (1) MA30892B1 (xx)
MX (1) MX2009006949A (xx)
NO (1) NO20092726L (xx)
NZ (1) NZ576583A (xx)
RU (1) RU2449791C2 (xx)
SA (1) SA07280720B1 (xx)
TN (1) TN2009000258A1 (xx)
TW (1) TWI415631B (xx)
UA (1) UA96977C2 (xx)
WO (1) WO2008080968A1 (xx)
ZA (1) ZA200903115B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102151249A (zh) * 2010-02-11 2011-08-17 石药集团中奇制药技术（石家庄）有限公司 一种长春氟宁的药用组合物
JO3112B1 (ar) * 2010-03-29 2017-09-20 Ferring Bv تركيبة دوائية سريعة التحلل
CN102772373B (zh) * 2011-05-11 2015-09-02 石药集团中奇制药技术（石家庄）有限公司 一种注射用酒石酸长春瑞滨粉针剂及其制备方法
CN118286868A (zh) * 2018-08-31 2024-07-05 富士胶片欧文科技有限公司 用于混合设备的排气系统

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1170152B (it) * 1982-07-19 1987-06-03 Lilly Co Eli Miglioramenti a o riguardanti formulazioni di vinca-alcaloidi
US4619935A (en) * 1983-03-17 1986-10-28 Eli Lilly And Company Stable oncolytic formulations
US4923876A (en) * 1988-04-18 1990-05-08 Cetus Corporation Vinca alkaloid pharmaceutical compositions
HUT54308A (en) * 1989-04-04 1991-02-28 Lilly Co Eli Process for producing immunoglobulin conjugates and medicaments comprising same
US6143276A (en) * 1997-03-21 2000-11-07 Imarx Pharmaceutical Corp. Methods for delivering bioactive agents to regions of elevated temperatures
FR2761990B1 (fr) * 1997-04-10 1999-06-25 Pf Medicament Derives halogenes antimitotiques d'alcaloides de vinca
BRPI0307802B8 (pt) * 2002-02-22 2021-05-25 Merck Sharp & Dohme formulação farmacêutica compreendendo temozolomida, processo para a produção da mesma, bem como artigo fabricado contendo pó liofilizado compreendendo temozolomida
FR2863891B1 (fr) * 2003-12-23 2006-03-24 Pf Medicament Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
KR101223366B1 (ko) * 2004-05-03 2013-01-16 헤르메스 바이오사이언스, 인코포레이티드 약물 전달에 유용한 리포좀
US7879828B2 (en) * 2005-03-14 2011-02-01 Wyeth Llc Tigecycline compositions and methods of preparation

Also Published As

Publication number Publication date
TN2009000258A1 (en) 2010-10-18
EP2120934A1 (en) 2009-11-25
EP2120934B1 (en) 2014-05-07
AU2007341231A1 (en) 2008-07-10
HK1130439A1 (en) 2009-12-31
UA96977C2 (ru) 2011-12-26
AR064715A1 (es) 2009-04-22
IL199556A (en) 2014-09-30
KR20090097883A (ko) 2009-09-16
US8304424B2 (en) 2012-11-06
RU2009128327A (ru) 2011-02-10
CN101534821B (zh) 2012-01-25
RU2449791C2 (ru) 2012-05-10
TW200833369A (en) 2008-08-16
NZ576583A (en) 2012-01-12
CA2673232A1 (en) 2008-07-10
CN101534821A (zh) 2009-09-16
MX2009006949A (es) 2009-07-14
CL2007003838A1 (es) 2008-07-04
US20100087473A1 (en) 2010-04-08
FR2910812B1 (fr) 2009-03-20
WO2008080968A1 (en) 2008-07-10
SA07280720B1 (ar) 2012-02-07
NO20092726L (no) 2009-07-20
FR2910812A1 (fr) 2008-07-04
BRPI0722076A2 (pt) 2014-04-08
TWI415631B (zh) 2013-11-21
JP2010514737A (ja) 2010-05-06
AU2007341231B2 (en) 2013-03-21
MA30892B1 (fr) 2009-11-02

Similar Documents

Publication Publication Date Title
IL275854A (en) Pharmaceutical composition and its administration
IL197451A (en) History of Phenylamino and 4-Phenylalkylamino Quinazoline and Pharmaceuticals Containing It
ZA200902084B (en) Combination therapy with SGLT-2 inhibitors and their pharmaceutical compositions
EP1855750A4 (en) DEVICE FOR DELIVERING DRUG BY NEBULIZATION, WITH LATCH DETECTION AND TEMPERATURE PROTECTION
IL196601A0 (en) Pyrimidine derivatives and pharmaceutical compositions containing the same
IL193164A0 (en) Polymeric conjugates of 7-ethyl-10-hydroxycamptothecin and pharmaceutical compositions containing the same
IL184758A0 (en) New pharmaceutical compositions useful in the transmucosal administration of drugs
IL191902A0 (en) Azaindole derivatives and pharmaceutical compositions containing the same
EP2219616A4 (en) TAXAN DERIVATIVES LYOPHILIZED PHARMACEUTICAL COMPOSITION WITH IMPROVED STABILITY AND MANUFACTURING METHOD THEREFOR
IL199265A (en) Oxindol derivatives are converted and used to make a drug
IL188744A0 (en) High drug load formulations and dosage forms
IL193211A (en) Derivatives of Indzol-Troaril and pharmaceutical preparations containing them
IL192596A (en) Pharmaceutical preparations containing combinations of triazine derivatives and insulin secretion stimulants and their use in the preparation of medicines
EP1993590A4 (en) COMPOSITIONS AND METHODS FOR DELIVERY OF GDNF LIGAND FAMILY PROTEINS
ATE555791T1 (de) Pharmazeutische zusammensetzung enthaltend gestagene und/oder estrogene und 5-methyl-(6s)- tetrahydrofolat
ZA200903115B (en) Freeze-dried injectable pharmaceutical combination of semisynthetic vinca alkaloids and carbohydrate stable at room temperature
IL199168A (en) Indolysin derivatives and their use in the preparation of anti-diabetic drugs
EP2219640A4 (en) TAXAN DERIVATIVES LYOPHILIZED PHARMACEUTICAL COMPOSITION WITH IMPROVED RECONSTITUTION TIME AND METHOD OF MANUFACTURING THEREOF
IL197273A0 (en) Pharmaceutical and sunscreen compositions comprising caspase-14
IL195639A0 (en) Tricyclic compound and pharmaceutical use thereof
IL184697A0 (en) Injectable preparations of diclofenic and its pharmaceutically acceptable salts
EP1981569A4 (en) NADELLOSIS INDIVIDUAL DOSE ADMINISTRATION OF ANTITHROMBOSE MEDICINES
IL194906A0 (en) Triphenylmethylphosphonate ester derivatives and pharmaceutical compositions containing the same
IL191922A0 (en) Pharmaceutical formulations of oxcarbazepine and methods for its preparation
PL1655026T3 (pl) Zawierające diacereinę i meloksikam stałe preparaty farmaceutyczne